Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Journal of virology - 1 Dec 2016

Wu Yan, Gao Feng, Qi Jianxun, Bi Yuhai, Fu Lifeng, Mohan Sankar, Chen Yuhang, Li Xuebing, Pinto B Mario, Vavricka Christopher J, Tien Po, Gao George F

Abstract excerpt

Influenza virus neuraminidase (NA) drug resistance is one of the challenges to preparedness against epidemic and pandemic influenza virus infections. NA N1- and N2-containing influenza viruses are the primary cause of seasonal epidemics and past pandemics. The structural and functional basis underlying drug resistance of the influenza virus N1 NA is well characterized. Yet drug resistance of the N2 strain is not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Inhibitors

Share to Influenza A virus

Share to Neuraminidase

Share to Oseltamivir

Share to Viral Proteins

Share to Zanamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 27654293
DOI: 10.1128/JVI.01703-16
PMCID: PMC5110174

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.PMID 27654293Read ↗

In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 NeuraminidaseSemantic proximity Read ↗

Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.Semantic proximity Read ↗

Structural insight into the mechanism of neuraminidase inhibitor-resistant mutations in human-infecting H10N8 Influenza A virusSemantic proximity Read ↗

H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis.Semantic proximity Read ↗

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.Semantic proximity Read ↗

Structural basis for oseltamivir resistance of influenza viruses.Semantic proximity Read ↗

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.Semantic proximity Read ↗

Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.Semantic proximity Read ↗

Computational studies of H5N1 influenza virus resistance to oseltamivir.Semantic proximity Read ↗

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.